2024-519215-33-00Active, not recruitingPhase 1
A Study to Learn How Different Amounts of the Study Medicine Called PF-07985631 are Tolerated and Act in the Body in Healthy Adults
Source: EU CTIS (euclinicaltrials.eu) · Last updated 5 Jun 2026
- Status (registry)
- Active, not recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 92 (estimated)
- First submitted
- 15 May 2025
- Start date
- 7 Aug 2025
- Lead sponsor
- Pfizer Inc.
- EU CT number
- 2024-519215-33-00
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 92
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Pfizer Clinical Research Unit | Brussels | Belgium | Active, not recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.